Innovation: early diagnosis in community settings
This report focuses on early diagnosis of heart failure in community settings, identifying four key areas of innovation.
Find out more
From guidelines to action
This project aims to help the heart failure community advocate for change to close the gap between clinical guidelines and the reality of care for people living with heart failure.
Find out more
Spotlight series
The Spotlight series features evidence-based reports on topics at the forefront of debates about the future of heart failure care.
Find out more
heart graphic

Helping advance meaningful policy change on heart failure

The Heart Failure Policy Network is an independent, multidisciplinary platform of healthcare professionals, advocacy groups and policymakers from across Europe.

We aim to raise awareness of the unmet needs surrounding heart failure and its care, and to help drive meaningful changes in policy and practice.

Find out more
Latest
New briefing provides heart failure advocates with actionable ways to improve access to best-practice care in Germany
15 May 2023

The final advocacy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Germany.

Read article
Latest
Tackling the overlooked epidemic of heart failure in Germany
4 May 2023

Heart failure is prevalent in Germany, but is under-recognised. Key stakeholders came together at the German Heart Failure Roundtable to discuss the need for policy change and comprehensive investment in heart failure care.

Read article
Latest
New briefing highlights actions to ensure access to best-practice heart failure care in Italy
13 April 2023

The latest policy briefing in our From guidelines to action series highlights the opportunities for heart failure advocates to improve care in Italy.

Read article
heart failure graphic
What is heart failure?

Affecting at least 15 million adults in Europe, heart failure is a common but complex clinical syndrome that occurs when the heart is unable to pump enough blood to meet body’s needs.

Its prevalence is expected to rise due to population ageing and improved survival rates for other long-term conditions, including cardiovascular diseases.

Find out more
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .